R&D

News

Janssen adds Hemera's AMD gene therapy to pipeline

Johnson & Johnson’s pharma unit Janssen has bought rights to an investigational gene therapy for a severe form age-related macular degeneration from specialist biotech Hemera Bioscience

News

DNA strand and Cancer Cell Oncology Research Concept 3D rendering

Merck KGaA signs DNA damage response cancer deal with Artios...

Germany’s Merck KGaA has joined with UK-based Artios Pharma in a potential multi-billion dollar deal to investigate novel DNA damage response targets in cancer.

Partner Content

First results of the DiabetRisk study

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Swiss start-up Noema raises $59m to develop neurology drugs ...

Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in from Roche.

News

Pfizer/BioNTech say COVID-19 vaccine could be approved in Eu...

Pfizer and BioNTech have filed their COVID-19 vaccine with the European medicines regulator, paving the way for a potential approval before the end of the year.

News